Conversely, circulating levels of ANGPT2, which acts as a context-dependent antagonist of TIE2, increase in CKD patients and correlate with adverse cardiovascular and renal outcomes (27–31). The gene discussed is ANGPT2; the disease is chronic kidney disease.